CME Group’s Target Raised at Jefferies; Long-Term Still Looks Good (CME)

By
A A A
Share |

Futures exchange operator CME Group Inc ( CME ) on Wednesday caught some further positive commentary from analysts at Jefferies & Co.

The firm maintained its "Buy" rating on CME and lifted its price target to $325, suggesting a nearly 13% upside to the stock's Tuesday closing price of $288.40. Jefferies noted that long-term trends for the company remain favorable.

CME Group shares, which have rise 18% year-to-date, fell $2.39, or -0.8%, in premarket trading Wednesday.

The Bottom Line
We have been recommending shares of CME Group ( CME ) since Feb.3, 2012, when the stock was trading at $266.01. The company has a 3.09% dividend yield, based on last night's closing stock price of $288.40.

CME Group Inc ( CME ) is a "Recommended" dividend stock, holding a Dividend.com DARS™ Rating of 3.5 out of 5 stars.

Be sure to visit our complete recommended list of the Best Dividend Stocks , as well as a detailed explanation of our ratings system here .



The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.

Created by Dividend.com


This article appears in: Investing , Stocks

Referenced Stocks: CME

Dividend.com

Dividend.com

More from Dividend.com:

Related Videos

Stocks

Referenced

100%

Most Active by Volume

63,103,769
  • $14.905 ▼ 2.26%
31,465,546
  • $94.28 ▼ 0.78%
27,470,101
    $38.32 unch
26,558,467
  • $3.34 ▼ 1.18%
25,343,966
  • $95.61 ▲ 0.01%
23,817,443
  • $71.84 ▼ 1.11%
21,868,080
  • $3.955 ▲ 1.15%
19,828,898
  • $3.8501 ▲ 10.95%
As of 8/1/2014, 12:30 PM